Skip to Main content Skip to Navigation
New interface
Journal articles

Repliement et production de proteines recombinantes

Abstract : The biotechnology of recombinant protein production is now entering its most advanced stage, and the growth of industrial protein pharmaceuticals provides solid proof of this evolution. However, the systematic conversion of genetic information into a biologically active protein is constantly confronted by the fundamental problem of protein folding in cells, and many recombinant proteins are not produced in their native state. Instead, they aggregate into a biologically inactive state. Although this aggregation reaction has some practical advantages, in vitro renaturation of recombinant proteins, after solubilization of cellular aggregates, is still an empiric and random process. Thus, it is better to control cellular expression conditions to minimize this problem inside the cells. The most attractive approach is certainly the development of high throughput genetic screens to monitor efficient protein folding.
Complete list of metadata
Contributor : Cécile Roux Connect in order to contact the contributor
Submitted on : Friday, January 7, 2011 - 4:26:44 PM
Last modification on : Thursday, April 7, 2022 - 10:10:20 AM

Links full text




Jean-Michel Betton, Alain Chaffotte. Repliement et production de proteines recombinantes. médecine/sciences, 2005, 21 (6-7), pp.613-7. ⟨10.1051/medsci/2005216-7613⟩. ⟨pasteur-00553606⟩



Record views